IP15-14: Distinct SRD5A2-reduced Subtypes of Benign Prostatic Hyperplasia Exhibit p-AMPK/Rab9a/PLIN3-Mediated Lipophagic Compensation for Androgen Signaling Defects

IP15-14: Distinct SRD5A2-reduced Subtypes of Benign Prostatic Hyperplasia Exhibit p-AMPK/Rab9a/PLIN3-Mediated Lipophagic Compensation for Androgen Signaling Defects

Friday, May 15, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)

146B

Abstract

Speakers

ZHEMIN LIN

BeijingBeijing Shijitan Hospital

Sessions

IP15: Benign Prostatic Hyperplasia: Epidemiology, Evaluation & Medical Non-surgical Therapy

Friday, May 15, 2026 1:00 PM to 3:00 PM

Log in

See all the content and easy-to-use features by logging in or registering!